GCTK
GlucoTrack Inc
$
5.760
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
6.000
Open
5.950
VWAP
5.79
Vol
14.83K
Mkt Cap
3.27M
Low
5.750
Amount
85.86K
EV/EBITDA(TTM)
--
Total Shares
5.48M
EV
-5.55M
EV/OCF(TTM)
--
P/S(TTM)
--
Glucotrack, Inc. is focused on the design, development, and commercialization of technologies for people with diabetes. The Company is engaged in developing a long-term Implantable Continuous Blood Glucose Monitor (CBGM) for people living with Type 1 diabetes and insulin-dependent Type 2 diabetes. Its CBGM is a long-term, implantable system that continually measures blood glucose levels with a sensor longevity of 3 years, no on-body wearable component and with minimal calibration. Its CBGM technology allows for a less burdensome approach to glucose monitoring. It has also completed four animal studies with evolving prototype systems, all four of which consistently demonstrated a simple implant procedure, functionality, and safety. The Company has also demonstrated continuous glucose sensing in the epidural space via two additional animal trials, both of which demonstrated a simple implant procedure, functionality, and safety.
Show More
Get winning stock picks in minutes
Get winning stock picks in minutes
Valuation Metrics
The current forward P/E ratio for GlucoTrack Inc (GCTK.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess GlucoTrack Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00
Financials
Annual
Quarterly
FY2025Q1
N/A
Total Revenue
FY2025Q1
YoY :
+18.54%
-3.50M
Operating Profit
FY2025Q1
YoY :
+133.45%
-6.83M
Net Income after Tax
FY2025Q1
YoY :
-94.27%
-40.35
EPS - Diluted
FY2025Q1
YoY :
-1.77%
-2.95M
Free Cash Flow
FY2025Q1
N/A
Gross Profit Margin - %
FY2025Q1
N/A
FCF Margin - %
FY2025Q1
N/A
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
GCTK News & Events
Events Timeline
2025-08-06 (ET)
2025-08-06
08:38:59
GlucoTrack appoints David Hirsh as medical director, cardiology
2025-07-08 (ET)
2025-07-08
08:37:20
GlucoTrack announces repurchase of Series A warrants
2025-06-25 (ET)
2025-06-25
08:41:43
GlucoTrack announces study of CBGM met all primary endpoints
Sign Up For More Events
Sign Up For More Events
News
1.0
07-31NewsfilterGlucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting
2.0
07-21BenzingaWhy Block Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
8.0
07-08NewsfilterGlucotrack Announces Repurchase of Series A Warrants
Sign Up For More News
People Also Watch
FAQ
What is GlucoTrack Inc (GCTK) stock price today?
The current price of GCTK is 5.76 USD — it has decreased -2.04 % in the last trading day.
What is GlucoTrack Inc (GCTK)'s business?
What is the price predicton of GCTK Stock?
What is GlucoTrack Inc (GCTK)'s revenue for the last quarter?
What is GlucoTrack Inc (GCTK)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for GlucoTrack Inc (GCTK)'s fundamentals?
How many employees does GlucoTrack Inc (GCTK). have?